Biogen Inc. (ETR:IDP)
Germany
· Delayed Price · Currency is EUR 103.85
-1.65 (-1.56%)
Apr 25, 2025, 5:35 PM CET
Biogen Employees
Biogen had 7,605 employees as of December 31, 2024. The number of employees increased by 35 or 0.46% compared to the previous year.
Employees
7,605
Change (1Y)
35
Growth (1Y)
0.46%
Revenue / Employee
€1,228,922
Profits / Employee
€207,303
Market Cap
15.31B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Merck KGaA | 59,020 |
| Siemens Healthineers AG | 72,000 |
| Fresenius SE & Co. KGaA | 176,486 |
| Bayer Aktiengesellschaft | 90,587 |
| Sartorius Aktiengesellschaft | 13,528 |
| Fresenius Medical Care AG | 111,513 |
| Carl Zeiss Meditec AG | 5,730 |
| Fielmann Group AG | 23,412 |
Biogen News
- 2 days ago - Biogen: Is This A Value Trap, Or Is The Great Turnaround Imminent? - Seeking Alpha
- 11 days ago - Europe Approves Eisai-Biogen's Alzheimer's Drug 'Under Strict Conditions' After Initial Negative Opinion - Benzinga
- 12 days ago - Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer's Disease to be Authorized in the European Union - GlobeNewsWire
- 12 days ago - Biogen/ Eisai win EU approval for Alzheimer’s therapy - Seeking Alpha
- 12 days ago - EU authorizes Eisai-Biogen's drug for treatment of early Alzheimer's disease - Reuters
- 18 days ago - Sage Therapeutics: Biogen's $7.22/Share Bid Might Say More Than The Price Tag - Seeking Alpha
- 23 days ago - Vertex, Alnylam Best Positioned As Biopharma Braces For Tariff Impact, Goldman Sachs Flags Regeneron, Biogen Risks - Benzinga
- 23 days ago - Biogen downgraded to Hold at Argus on profit decline expectations - Seeking Alpha